SCHEMBL14433205

SCHEMBL14433205

Cc1c(COC2CCN(C(=O)OC(C)(C)C)CC2)ncn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 7/20 0.45
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
PRMT5 O14744 1/20 0.43
WDR77 Q9BQA1 1/20 0.43
CACNB4 O00305 1/20 0.43
CACNA1A O00555 1/20 0.43
CACNA1G O43497 1/20 0.43
CACNG3 O60359 1/20 0.43
CACNA1F O60840 1/20 0.43
CACNA1H O95180 1/20 0.43
CACNB3 P54284 1/20 0.43
CACNA2D1 P54289 1/20 0.43
CACNG7 P62955 1/20 0.43
CACNA1B Q00975 1/20 0.43
CACNA1D Q01668 1/20 0.43
CACNB1 Q02641 1/20 0.43
CACNG1 Q06432 1/20 0.43
CACNB2 Q08289 1/20 0.43
CACNA1S Q13698 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948957 0.85 KDM4E (0.48) GPR119KDM4EPKMSTSMEN1
SCHEMBL948117 0.81 GPR119 (0.49) GPR119KDM4EPKMPRMT5WDR77
SCHEMBL14433203 0.80 GPR119 (0.46) GPR119KDM4EPKMPRMT5WDR77
SCHEMBL948590 0.78 GPR119 (0.45) GPR119KDM4EPKMSTSMEN1
SCHEMBL948589 0.78 GPR119 (0.45) GPR119KDM4EPKMSTSMEN1
SCHEMBL3249107 0.77 STS (0.58) GPR119KDM4EPKMPRMT5WDR77
SCHEMBL16804450 0.75 GPR119 (0.49) GPR119KDM4EPKMPRMT5WDR77
SCHEMBL949394 0.74 KDM4E (0.45) GPR119KDM4EPKMSTSMEN1
SCHEMBL19839715 0.74 GPR119 (0.56) GPR119KDM4EPKMPRMT5WDR77
SCHEMBL23293089 0.74 GPR119 (0.52) GPR119KDM4EPKMPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185163-A1 Imidazol derivatives of piperidine as histamine antagonists ASTRAZENECA AB (SE) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185163-A1 Imidazol derivatives of piperidine as histamine antagonists HRH2, HRH1, HRH4 GPR119 179/4885KDM4E 1228/4885PKM 523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.